Pacira BioSciences (PCRX) Other Working Capital Changes (2010 - 2026)

Pacira BioSciences' Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$23000.0 for Q1 2023.

• On a quarterly basis, Other Working Capital Changes fell 227.78% year-over-year to -$23000.0 in Q1 2023; TTM through Mar 2023 was $51000.0, a 97.99% decrease from a year earlier, with the FY2022 full-year figure at $92000.0, down 96.56% from the prior year.
• Other Working Capital Changes climbed to -$23000.0 in Q1 2023 per PCRX's latest filing, from -$92000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $13.4 million in Q2 2025 and bottomed at -$12.7 million in Q4 2025.
• The 5-year median for Other Working Capital Changes is $2.1 million (2022), against an average of $791176.5.
• Across the five-year window, Other Working Capital Changes jumped 161.47% in 2021 and tumbled 387.5% in 2022, its largest moves.
• Year by year, Other Working Capital Changes stood at $1.2 million in 2020, then plunged by 97.24% to $32000.0 in 2021, then tumbled by 387.5% to -$92000.0 in 2022, then surged by 75.0% to -$23000.0 in 2023.
• Per Business Quant, the three latest PCRX Other Working Capital Changes figures stand at -$23000.0 (Q1 2023), -$92000.0 (Q4 2022), and $76000.0 (Q3 2022).